2023. A systematic review of preclinical animal studies on fenofibrate’s potential role in type 1 diabetic micro-vascular complications. Brazilian Journal of Pharmaceutical Sciences. 58, (Feb. 2023). DOI:https://doi.org/10.1590/s2175-97902022e21332.